IPO Calendar
Lead Manager
- J P Morgan Chase (515)
- Goldman Sachs (492)
- Morgan Stanley (445)
- Bank of America Merrill Lynch (374)
- Citigroup (236)
- Jefferies (223)
- Credit Suisse (180)
- Barclays (158)
- Cowen and Company (147)
- Deutsche Bank (85)
- Leerink Partners (73)
- Piper Jaffray (70)
- Stifel (67)
- UBS Investment Bank (56)
- Evercore (55)
- RBC Capital (53)
- BMO Capital (52)
- Wells Fargo (48)
- Piper Sandler (43)
- Revere Securities (42)
More +
IPO - Pricing (9)
Cowen and Company
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 5 | Turning Point B | Consumer-Non-Durables | 10 | 5 | COWN | FBR | 37% | 1.2% | |||
| Oct 27 | Myovant Science | Health-Care | 15 | 15 | BRCL | CITI | COWN | 37.8% | -11.6% | ||
| Jul 4 | Aeglea BioThera | Health-Care | 10 | 5 | BMO | COWN | UBS | 28.6% | -2.3% | ||
| Jun 30 | Syros Pharmaceu | Health-Care | 12.5 | 4 | COWN | PPRJ | 22% | 45.2% | |||
| May 26 | Reata Pharmaceu | Health-Care | 11 | 5 | CITI | COWN | 37.2% | 18.8% | |||
| Mar 23 | Corvus Pharmace | Health-Care | 15 | 4 | COWN | CS | 35% | -5% | |||
| Mar 2 | BeiGene Ltd. | Health-Care | 24 | 6 | MS | GS | COWN | 31.3% | 18% | ||
| Feb 6 | Clearside Biome | Health-Care | 7 | 7 | COWN | RBC | Stifel | 27.5% | 3.6% | ||
| Feb 6 | NantHealth Inc. | Technology | 14 | 6 | COWN | JEFF | 53.6% | 32.8% | |||
*
Lead manager or one of top three managers in an underwriting team.